U.S. Markets open in 8 hrs 40 mins

Bluebird Bio’s Q2 2018 Earnings: Analysts’ Estimates

Mike Benson
Bluebird Bio’s Q2 2018 Earnings: Analysts’ Estimates

Clinical-stage biotechnology company Bluebird Bio (BLUE) is set to release its Q2 2018 results tomorrow. The company has research and development collaborations with Celgene (CELG), TC BioPharm, Lonza, MediGene, and Apceth Biopharma.